Case Studies and Current Research
FMT Case Studies
Studies have shown that fecal microbiota transplantation (FMT) is a safe and highly efficient treatment. FMT safety and efficacy data in the treatment of RCDI is compelling and FMT should be the standard of care for patients who fail conventional antibiotic courses for the treatment of RCDI. It remains an interesting and promising option for patients with IBD.
FMT Research
Patients, and their microbiomes, are constantly being monitored following transplants to allow experts to better understand how they work, and which of the hundreds of different bacterial species are the ones responsible for the benefits. There is interest in using FMT against other conditions related to the microbiome, such as ulcerative colitis and diabetes.
*Disclaimer – information from patients and clincs worldwide. If you would like to contribute to the content of this website please email us on info@fmtresearch.co.uk